1-7 of 7
Hiroko Honna
Close
Sort by
Journal Articles

BCR-ABL Regulates Death Receptor Expression for TNF-Related Apoptosis-Inducing Ligand (TRAIL) in Philadelphia Chromosome-Positive Leukemia

Itaru Kuroda, MD, PhD, Takeshi Inukai, MD, PhD, Xiaochun Zhang, MD, PhD, Jiro Kikuchi, Yusuke Furukawa, Atsushi Nemoto, MD, PhD, Koshi Akahane, MD, PhD, Kinuko Hirose, MD, PhD, Hiroko Honna- Oshiro, MD, PhD, Kumiko Goi, MD, PhD, Keiko Kagami, Hideo Yagita, PhD, Tetsuzo Tauchi, M.D., Yasuhiro Maeda, MD, PhD, Kanji Sugita, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 2740.
https://doi.org/10.1182/blood.V118.21.2740.2740
Published: 2011
Journal Articles

PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Lymphoid Crisis of CML and Ph+ALL Even with T315I Mutation in BCR-Abl; in Vitro Analysis

Atsushi Nemoto, MD, PhD, Takeshi Inukai, MD, PhD, Koshi Akahane, MD, PhD, Hiroko Honna- Oshiro, MD, PhD, Kumiko Goi, MD, PhD, Keiko Kagami, Yasuhiro Maeda, MD, PhD, Tetsuzo Tauchi, M.D., Shinya Kimura, MD, PhD, Kanji Sugita, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 1511.
https://doi.org/10.1182/blood.V118.21.1511.1511
Published: 2011
Journal Articles

Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)

Kinuko Hirose, Takeshi Inukai, Jiro Kikuchi, Yusuke Furukawa, Tomokatsu Ikawa, Hiroshi Kawamoto, S. Helen Oram, Berthold Göttgens, Nobutaka Kiyokawa, Yoshitaka Miyagawa, Hajime Okita, Koshi Akahane, Xiaochun Zhang, Itaru Kuroda, Hiroko Honna, Keiko Kagami, Kumiko Goi, Hidemitsu Kurosawa, A. Thomas Look, Hirotaka Matsui, Toshiya Inaba, Kanji Sugita
Journal: Blood
Blood (2010) 116 (6): 962–970.
https://doi.org/10.1182/blood-2009-09-244673
Published: 2010
Includes: Supplemental data
Journal Articles

KIRs Expression and Cytotoxic Activities of Cord Blood Natural Killer Cells Against Acute Lymphoblastic Leukemia with MLL Gene Rearrangement.

Hiroko Honna, MD, Kumiko Goi, MD, Kinuko Hirose, MD, Itaru Kuroda, MD, Takeshi Inukai, MD, Keiko Kagami, Kanji Sugita, MD
Journal: Blood
Blood (2007) 110 (11): 2803.
https://doi.org/10.1182/blood.V110.11.2803.2803
Published: 2007
Journal Articles

Induction of Death Receptors for TRAIL, a Cytotoxic Factor for GVL Effect, by Oncogenic Fusion E2A-HLF Derived from t(17;19)-Positive Acute Lymphoblastic Leukemia.

Xiaochun Zhang, Takeshi Inukai, Koshi Akahane, Kinuko Hirose, Itaru Kuroda, Hiroko Honna, Kumiko Goi, Keiko Kagami, Toshiya Inaba, Hidemitsu Kurosawa, Hiroaki Goto, Mikiya Endo, Hideo Yagita, A. Thomas Look, Kanji Sugita
Journal: Blood
Blood (2007) 110 (11): 2785.
https://doi.org/10.1182/blood.V110.11.2785.2785
Published: 2007
Journal Articles

Analysis of NK Cell Alloreactivity Against Acute Leukemia Cells with MLL Gene Rearramgement.

Hiroko Honna, MD, Kumiko Goi, M.D., Kinuko Hirose, M.D., Itaru Kuroda, M.D., Takeshi Inukai, M.D., Keiko Kagami, Shinpei Nakazawa, M.D., Kanji Sugita, M.D.
Journal: Blood
Blood (2006) 108 (11): 5169.
https://doi.org/10.1182/blood.V108.11.5169.5169
Published: 2006
Journal Articles

E2A-HLF Fusion Transcription Factor Mediating Aberrant Expression of LMO2 in B-Precursor ALL with t(17;19).

Kinuko Hirose, Takeshi Inukai, Koshi Akahane, Xiaochun Zhang, Itaru Kuroda, Hiroko Honna, Kumiko Goi, Toshiya Inaba, A. Thomas Look, Shinpei Nakazawa, Kanji Sugita
Journal: Blood
Blood (2006) 108 (11): 1832.
https://doi.org/10.1182/blood.V108.11.1832.1832
Published: 2006